Dr. Jeffrey A. Zonder of the Barbara Ann Karmanos Cancer Institute explains why Right to Try falls short of expectations.
“We genuinely want to revolutionize how health care is paid for ... in an outcome-based, health-based, non-procedure-, non-sickness-based way.”
The result could be higher premiums for plans obtained through the Affordable Care Act online marketplaces.
From the Journals
Adherence to prophylaxis is generally high, but quality of life and disease coping matter.
WASHINGTON – “This is a dream deferred” for patients and families affected by sickle cell disease.
STOCKHOLM – The compound CAR T simultaneously targeted antigens in bulky disease and on leukemic stem cells in acute myeloid leukemia.
CHICAGO – Frontline use of chemoimmunotherapy is complicated.
CHICAGO – Fitzpatrick skin types I and II boost risk 7- to 9-fold.